Rosella-Dampman L M, Emmert S E, Keil L C, Summy-Long J Y
Brain Res. 1985 Jan 28;325(1-2):205-14. doi: 10.1016/0006-8993(85)90317-8.
The hypothalamo-neurohypophysial system is altered in the spontaneously hypertensive rat (SHR). We hypothesized that an aberrant regulation of vasopressin (VP) and oxytocin (OT) release by endogenous opioid peptides alters this neuroendocrine system in the SHR. Concentrations of the neurohypophysial hormones in plasma and the pituitary were measured in 17-week-old SHRs and two strains of normotensive controls. Wistar Kyoto (WKY) and Sprague-Dawley rats. Animals were decapitated 20 min after s.c. injection of saline (1 ml/kg) or naloxone hydrochloride (1 or 10 mg/kg). In addition, neurohypophysial hormones excreted during the day (08.00-17.30 h) and night (17.30-08.00 h) were determined in urine from 16-week-old animals kept in metabolic cages for 5 days. VP at extrahypothalamic sites was also measured as [VP] in acid extracts of the subfornical organ area, hippocampal commissure-fornix and choroid plexus. Hormones were quantified by radioimmunoassay. The pituitary content, plasma concentration, and urinary excretion of OT were reduced (P less than 0.05) in SHRs, whereas VP content was increased (P less than 0.05) in the pituitary and plasma, but unchanged in urine, of hypertensive animals. In extrahypothalamic tissues, [VP] in the hippocampal commissure-fornix was increased in the SHR. Naloxone elevated (P less than 0.05) the plasma concentration of OT in WKY animals and VP in SHRs. Neither [VP] nor [OT] in plasma was changed by naloxone in Sprague-Dawley rats. Pituitary stores of the neurohypophysial hormones were not altered by naloxone in either hypertensive or normotensive rats. In conclusion, endogenous opioid peptides tonically inhibit OT release in WKY rats, whereas VP release is decreased by opioid peptides in SHRs, 16-17 weeks of age. The neuromodulatory role of opioid peptides in the release of neurohypophysial hormones appears to be altered in the SHR such that VP release is suppressed and OT release is augmented.
自发性高血压大鼠(SHR)的下丘脑 - 神经垂体系统发生了改变。我们推测内源性阿片肽对血管加压素(VP)和催产素(OT)释放的异常调节改变了SHR中的这种神经内分泌系统。在17周龄的SHR以及两种正常血压对照品系(Wistar Kyoto大鼠(WKY)和Sprague - Dawley大鼠)中测量了血浆和垂体中神经垂体激素的浓度。在皮下注射生理盐水(1 ml/kg)或盐酸纳洛酮(1或10 mg/kg)20分钟后,将动物断头。此外,在代谢笼中饲养5天的16周龄动物的尿液中,测定了白天(08:00 - 17:30)和夜间(17:30 - 08:00)排泄的神经垂体激素。还测量了穹窿下器区域、海马连合 - 穹窿和脉络丛酸提取物中作为[VP]的下丘脑外部位的VP。通过放射免疫测定法定量激素。SHR中OT的垂体含量、血浆浓度和尿排泄量降低(P < 0.05),而高血压动物垂体和血浆中的VP含量增加(P < 0.05),但尿液中VP含量未改变。在SHR的下丘脑外组织中,海马连合 - 穹窿中的[VP]增加。纳洛酮使WKY动物的血浆OT浓度和SHR的血浆VP浓度升高(P < 0.05)。在Sprague - Dawley大鼠中,纳洛酮未改变血浆中的[VP]和[OT]。在高血压或正常血压大鼠中,纳洛酮均未改变神经垂体激素的垂体储存量。总之,内源性阿片肽在16 - 17周龄的WKY大鼠中持续抑制OT释放,而在SHR中阿片肽使VP释放减少。阿片肽在神经垂体激素释放中的神经调节作用在SHR中似乎发生了改变,使得VP释放受到抑制而OT释放增加。